Judge OKs Mylan's Acne Generic But Keeps Patent Intact
A New Jersey federal judge on Monday held that two generic anti-acne drugs made by Mylan Pharmaceuticals Inc. and Impax Laboratories Inc. do not infringe a patent for Warner Chilcott Co....To view the full article, register now.
Already a subscriber? Click here to view full article